Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200686

PIMECROLIMUS
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC

Basic Information

ChEMBL ID CHEMBL1200686
Name PIMECROLIMUS
Phase Approved
Structure Type MOL
InChI Key KASDHRXLYQOAKZ-XDSKOBMDSA-N
Therapeutic ✓ Yes

Known Names

(-)-pimecrolimus Elidel Pimecrolimus SDZ ASM 981 SDZ ASM-981 SDZ-ASM 981 SDZ-ASM-981
1
Targets
1
Activities
1
Assay Types
1
PK Parameters
20
Publications
7
Known Names
11
Indications
1
Mechanisms

Molecular Properties

810.5
MW (Da)
5.72
ALogP
11
HBA
2
HBD
158.1
PSA (Ų)
0.15
QED
3
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2001
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Topical

Flags

Black Box Warning Natural Product
USAN Stem -imus
USAN Year 2000

Extended Properties

Molecular Formula C43H68ClNO11
MW 810.47
Aromatic Rings 0
Heavy Atoms 56
NP-Likeness 1.33

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
FK506-binding protein 1A inhibitor INHIBITOR Peptidyl-prolyl cis-trans isomerase FKBP1A

Indications

Dermatitis, Atopic Eczema Dermatitis Dermatitis, Perioral Lichen Planus Dermatitis, Seborrheic Dry Eye Syndromes Lichen Planus, Oral Lichen Sclerosus et Atrophicus Vitiligo Netherton Syndrome

ATC Classification

D11AH02
pimecrolimus
Level 1: DERMATOLOGICALS
Level 2: OTHER DERMATOLOGICAL PREPARATIONS

Drug Warnings

Black Box Warning
carcinogenicity
Country: United States

Activity Summary

IC50 1 meas. best 5.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Bile salt export pump
CHEMBL6020
IC50 5.0 5.0 10000.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 18.64 ng.hr.mL-1 Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Bile salt export pump IC50 = 10000.0 nM 5.0 Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as... 23956101

Literature References

PubMed DOI Target Context # Activities
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
37468498 10.1038/s41467-023-40064-9 Thromboxane A2 receptor 2
37468498 10.1038/s41467-023-40064-9 Prostaglandin G/H synthase 1 2
23956101 10.1093/toxsci/kft176 Homo sapiens 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M1 2
37468498 10.1038/s41467-023-40064-9 Sodium-dependent dopamine transporter 1
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 1
37468498 10.1038/s41467-023-40064-9 Amine oxidase [flavin-containing] A 1
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent serotonin transporter 1
37468498 10.1038/s41467-023-40064-9 Sodium-dependent noradrenaline transporter 1
37468498 10.1038/s41467-023-40064-9 Acetylcholinesterase 1
37468498 10.1038/s41467-023-40064-9 Estrogen receptor 1
37468498 10.1038/s41467-023-40064-9 D(1A) dopamine receptor 1
- 10.1101/2020.04.21.054387 SARS-CoV-2 1
23956101 10.1093/toxsci/kft176 Unchecked 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 4 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 3 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 2 1

Data from ChEMBL 36 via Core Engine